EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.

Durkin, Alan J

EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma. [electronic resource] - The Journal of surgical research Sep 2006 - 195-201 p. digital

Publication Type: Journal Article

0022-4804

10.1016/j.jss.2006.03.010 doi


Adenocarcinoma--drug therapy
Animals
Cell Division--drug effects
Cell Line, Tumor
Disease Models, Animal
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Gene Expression
Humans
Mice
Mice, Nude
Pancreatic Neoplasms--drug therapy
Phenylalanine--analogs & derivatives
Protease Inhibitors--pharmacology
Protein Kinase Inhibitors--pharmacology
Quinazolines--pharmacology
Survival Rate
Thiophenes--pharmacology